E
nDatalyze Corp.
NDAT
CNSX
E
Sell
6/11/2024Downgrade
nDatalyze Corp. (NDAT) was downgraded to E+ from D- on 6/11/2024 due to a decline in the volatility index.
nDatalyze Corp. (NDAT) was downgraded to E+ from D- on 6/11/2024 due to a decline in the volatility index.
D
Sell
5/22/2024Upgraded
nDatalyze Corp. (NDAT) was upgraded to D- from E+ on 5/22/2024 due to an increase in the volatility index, total return index and solvency index.
nDatalyze Corp. (NDAT) was upgraded to D- from E+ on 5/22/2024 due to an increase in the volatility index, total return index and solvency index.
E
Sell
6/13/2023Downgrade
nDatalyze Corp. (NDAT) was downgraded to E+ from D- on 6/13/2023 due to a large decline in the total return index, volatility index and growth index.
nDatalyze Corp. (NDAT) was downgraded to E+ from D- on 6/13/2023 due to a large decline in the total return index, volatility index and growth index.
D
Sell
3/14/2023Downgrade
nDatalyze Corp. (NDAT) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index.
nDatalyze Corp. (NDAT) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index.
D
Sell
2/23/2023Upgraded
nDatalyze Corp. (NDAT) was upgraded to D from D- on 02/23/2023.
nDatalyze Corp. (NDAT) was upgraded to D from D- on 02/23/2023.
D
Sell
2/8/2023Downgrade
nDatalyze Corp. (NDAT) was downgraded to D- from D on 2/8/2023 due to a significant decline in the total return index, solvency index and volatility index. The quick ratio declined from 119.94 to 82.08.
nDatalyze Corp. (NDAT) was downgraded to D- from D on 2/8/2023 due to a significant decline in the total return index, solvency index and volatility index. The quick ratio declined from 119.94 to 82.08.
D
Sell
6/21/2022Downgrade
nDatalyze Corp. (NDAT) was downgraded to D from D+ on 6/21/2022 due to a large decline in the growth index, efficiency index and valuation index. EBIT declined 7,864.84% from $9.1 to -$706.6, operating cash flow declined 2,214.14% from -$30.4 to -$703.5, and net income declined 2,191.27% from -$33.2 to -$760.7.
nDatalyze Corp. (NDAT) was downgraded to D from D+ on 6/21/2022 due to a large decline in the growth index, efficiency index and valuation index. EBIT declined 7,864.84% from $9.1 to -$706.6, operating cash flow declined 2,214.14% from -$30.4 to -$703.5, and net income declined 2,191.27% from -$33.2 to -$760.7.
D
Sell
1/31/2022Downgrade
nDatalyze Corp. (NDAT) was downgraded to D+ from C- on 1/31/2022 due to a decline in the valuation index.
nDatalyze Corp. (NDAT) was downgraded to D+ from C- on 1/31/2022 due to a decline in the valuation index.
C
Hold
1/14/2022Upgraded
nDatalyze Corp. (NDAT) was upgraded to C- from D+ on 1/14/2022 due to a noticeable increase in the growth index, total return index and valuation index. EBIT increased 168.15% from -$13.5 to $9.2, earnings per share increased from -$0.002 to -$0.0009, and operating cash flow increased 0.65% from -$30.6 to -$30.4.
nDatalyze Corp. (NDAT) was upgraded to C- from D+ on 1/14/2022 due to a noticeable increase in the growth index, total return index and valuation index. EBIT increased 168.15% from -$13.5 to $9.2, earnings per share increased from -$0.002 to -$0.0009, and operating cash flow increased 0.65% from -$30.6 to -$30.4.
D
Sell
11/30/2021Upgraded
nDatalyze Corp. (NDAT) was upgraded to D+ from D on 11/30/2021 due to a substantial increase in the total return index.
nDatalyze Corp. (NDAT) was upgraded to D+ from D on 11/30/2021 due to a substantial increase in the total return index.
D
Sell
10/11/2021Downgrade
MedXtractor Corp. (MXT) was downgraded to D from D+ on 10/11/2021 due to a decline in the solvency index and total return index. The quick ratio declined from 139.74 to 120.5.
MedXtractor Corp. (MXT) was downgraded to D from D+ on 10/11/2021 due to a decline in the solvency index and total return index. The quick ratio declined from 139.74 to 120.5.
D
Sell
7/9/2021Upgraded
MedXtractor Corp. (MXT) was upgraded to D+ from D on 7/9/2021 due to a large increase in the total return index, solvency index and volatility index. The quick ratio increased from 10.87 to 139.74.
MedXtractor Corp. (MXT) was upgraded to D+ from D on 7/9/2021 due to a large increase in the total return index, solvency index and volatility index. The quick ratio increased from 10.87 to 139.74.
D
Sell
11/2/2020Upgraded
MedXtractor Corp. (MXT) was upgraded to D from D- on 11/2/2020 due to a significant increase in the efficiency index, growth index and valuation index. Total revenue increased 82.28% from $68.3 to $124.5, EBIT increased 58% from $15 to $23.7, and earnings per share increased from $0.0004 to $0.0005.
MedXtractor Corp. (MXT) was upgraded to D from D- on 11/2/2020 due to a significant increase in the efficiency index, growth index and valuation index. Total revenue increased 82.28% from $68.3 to $124.5, EBIT increased 58% from $15 to $23.7, and earnings per share increased from $0.0004 to $0.0005.
D
Sell
7/1/2020Upgraded
MedXtractor Corp. (MXT) was upgraded to D- from E on 7/1/2020 due to a noticeable increase in the volatility index, total return index and growth index. Earnings per share increased from -$0.0002 to $0.0004, and EBIT increased 199.34% from -$15.1 to $15.
MedXtractor Corp. (MXT) was upgraded to D- from E on 7/1/2020 due to a noticeable increase in the volatility index, total return index and growth index. Earnings per share increased from -$0.0002 to $0.0004, and EBIT increased 199.34% from -$15.1 to $15.
E
Sell
4/1/2020Upgraded
MedXtractor Corp. (MXT) was upgraded to E from E- on 4/1/2020 due to an increase in the valuation index.
MedXtractor Corp. (MXT) was upgraded to E from E- on 4/1/2020 due to an increase in the valuation index.
E
Sell
1/22/2020None
nDatalyze Corp. (NDAT) was downgraded to E- from U on 01/22/2020.
nDatalyze Corp. (NDAT) was downgraded to E- from U on 01/22/2020.
